Advertisement

The Scientist

» clinical trials and neuroscience

Most Recent

image: Capsule Reviews

Capsule Reviews

By | June 1, 2012

The Aha! Moment, Imagine, Ignorance, and The Age of Insight

0 Comments

image: Best Places to Work Industry, 2012

Best Places to Work Industry, 2012

By | June 1, 2012

Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.

0 Comments

image: Active Brains Help Heal Paralysis

Active Brains Help Heal Paralysis

By | May 31, 2012

Engaging the brain with cognitive tasks helps paralyzed rats walk again.

4 Comments

image: 2012 Kavli Prize Winners

2012 Kavli Prize Winners

By | May 31, 2012

Biennial Kavli Prizes are presented to scientists in astrophysics, nanoscience, and neuroscience.

0 Comments

image: Trials Overlook Cancer Spread

Trials Overlook Cancer Spread

By | May 30, 2012

One cancer researcher says that by focusing solely on stalling cancer growth, clinical trials are failing some potentially life-saving drugs that prevent metastasis.

0 Comments

image: Next Generation: The Brain Bot

Next Generation: The Brain Bot

By | May 29, 2012

A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.

0 Comments

image: Pain-Killing Transplants

Pain-Killing Transplants

By | May 23, 2012

Neurons injected into mice help treat chronic pain at its roots, rather than simply alleviating its symptoms.

1 Comment

image: Overhauling Industry-Sponsored Studies

Overhauling Industry-Sponsored Studies

By | May 23, 2012

Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.

1 Comment

image: Battlefield Head Trauma

Battlefield Head Trauma

By | May 17, 2012

A new study suggests that the brain injuries suffered by soldiers in Afghanistan may be similar to those observed in some athletes.

0 Comments

image: Opinion: Misleading Drug Trials

Opinion: Misleading Drug Trials

By | May 14, 2012

Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.

23 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
RayBiotech
RayBiotech

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Myriad RBM
Myriad RBM
Advertisement
The Scientist
The Scientist